Mateos, M., Hari, P., Bahlis, N., Chari, A., van de Donk, N., Dholaria, B., Garfall, A., Goldschmidt, H., Kortüm, K., Krishnan, A., Martin, T., Morillo, D., Oriol, A., Reece, D., Rodriguez, C., Rodríguez-Otero, P., San-Miguel, J., Usmani, S., Verona, R., Lin, S., Prior, T., Wade, M., Weiss, B., Goldberg, J., & Askari, E. (n.d.). b06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS. HemaSphere, 6, 9. http://access.bl.uk/ark:/81055/vdc_100153435583.0x000032